Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genetics
Does MBD4 associated neoplasia syndrome predispose a patient to increased risk of side effects or secondary malignancy with radiation?
For a breast conserving surgery patient.
Related Questions
When should the dissected axilla (levels I-II) be included when delivering RNI?
What dose and fractionation would you deliver to the sole of the foot in a patient with multifocal cutaneous DLBCL that is resistant to systemic therapy?
Given the results of PLATO anal cancer study, is 4140 cGy the new standard for early stage anal cancer?
What dose/fractionation would you recommend for a prostate patient who previously received 1 of 5 planned fractions SBRT in 2020?
How do you consider SBRT relative to other emerging therapies for pediatric sarcomas, such as proton therapy or immunotherapy, in terms of efficacy and safety?
How would you treat a patient with a post prostatectomy biochemical and pelvic nodal recurrence with a BLM mutation?
Do you recommend self-breast exams to your patients with history of breast cancer in addition to imaging surveillance?
How would you treat a perineural IgG4-RD with persistent paresthesia?
Would you consider adjuvant immunotherapy for a patient with high-risk (N3 nodes) Merkel cell carcinoma following definitive surgical resection and adjuvant radiation therapy?
What is your approach to adjuvant RT or chemoRT in LS-SCLC s/p lobectomy with N1 disease?